Officials said the partnership will ensure residents in the area have access to more cancer treatments, such as clinical trials typically only available at comprehensive care facilities, according to the article. Gov. Chris Christie, University Hospital CEO John Kastanis, Rutgers President Robert Barchi and other state officials announced the partnership on Sept. 20.
The program will be housed on the Rutgers Cancer Institute’s Newark campus.
“As an NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey has the expertise to offer the latest treatment options and clinical trials as well as opportunities to reduce cancer incidence and improve patient outcomes,” said Bruce Haffty, interim director of Rutgers Cancer Institute of New Jersey. “Residents in the greater Newark area have a unique need for the most rigorous education, research and best care available, and this new partnership between Rutgers Cancer Institute and UniversityHospital will result in additional care options.”
More articles on transactions and valuations:
MD Anderson to affiliate with Deaconess Health System
Children’s Mercy, Olathe Medical Center partner on pediatric facility
Brookhaven Memorial Hospital Medical Center approves purchase of former nursing home facility
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
